David L. Kaplan
0000-0002-9245-7774
Publication & Citation Trends
Publications
2,351 total
Biologic initiation rates in systemic-naive psoriasis patients after first-line apremilast versus methotrexate use. OA
Cited by 2
Semantic Scholar
Real-world health outcomes in US adult patients with mild to moderate plaque psoriasis taking topical therapy
Cited by 0
Semantic Scholar
27722 Biologic initiation rates in psoriasis after first-line systemic use of apremilast vs methotrexate
Cited by 0
Semantic Scholar
Switch rates and total cost associated with apremilast and biologics in biologic-naive patients with psoriatic arthritis. OA
Cited by 2
Semantic Scholar
26603 Real-world health outcomes in US adult patients with mild-to-moderate plaque psoriasis taking topical therapy: Results from a chart review
Cited by 0
Semantic Scholar
CEOR_A_251775 369..377
Cited by 0
Semantic Scholar
16442 Examining psoriasis treatment patterns and temporal trends from 2012 to 2018
Cited by 0
Semantic Scholar
Switch Rates and Total Cost of Care Associated with Apremilast and Biologic Therapies in Biologic-Naive Patients with Plaque Psoriasis OA
Cited by 8
Semantic Scholar
Research Topics
Silk-based biomaterials and applications
(1035)
Electrospun Nanofibers in Biomedical Applications
(342)
Bone Tissue Engineering Materials
(223)
Biochemical and Structural Characterization
(196)
3D Printing in Biomedical Research
(144)
Affiliations
Université Paris-Sud
Rutgers, The State University of New Jersey
Boston College
Kettering Foundation
University of Notre Dame